Cumberland Pharmaceuticals (CPIX) Cash from Discontinued Operations (2019 - 2021)
Cumberland Pharmaceuticals' Cash from Discontinued Operations history spans 3 years, with the latest figure at 503318.0 for Q4 2021.
- On a quarterly basis, Cash from Discontinued Operations fell 62.78% to 503318.0 in Q4 2021 year-over-year; TTM through Sep 2022 was 503318.0, a 82.3% decrease, with the full-year FY2021 number at 1994322.0, down 43.31% from a year prior.
- Cash from Discontinued Operations hit 503318.0 in Q4 2021 for Cumberland Pharmaceuticals, up from 496787.0 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for CPIX hit a ceiling of 3027800.0 in Q4 2019 and a floor of 38567.0 in Q2 2020.
- Historically, Cash from Discontinued Operations has averaged 918680.0 across 3 years, with a median of 648983.5 in 2020.
- Biggest five-year swings in Cash from Discontinued Operations: tumbled 97.11% in 2020 and later skyrocketed 1193.35% in 2021.
- Tracing CPIX's Cash from Discontinued Operations over 3 years: stood at 3027800.0 in 2019, then tumbled by 55.34% to 1352156.0 in 2020, then crashed by 62.78% to 503318.0 in 2021.
- Business Quant data shows Cash from Discontinued Operations for CPIX at 503318.0 in Q4 2021, 496787.0 in Q3 2021, and 498807.0 in Q2 2021.